Prostate cancer screening has yet to prove its worth

The recent release of two large randomised trials suggests that if there is a benefit of screening, it is, at best, small, says a new report in CA: A Cancer Journal for Clinicians. Authored by Otis W. Brawley, M.D. of the American Cancer Society and Donna Ankerst, Ph.D. and Ian M. Thompson, M.D. of the University of Texas Health Science Centre at San Antonio, the review says because prostate cancer is virtually ubiquitous in men as they age, it is clear that a goal of 'finding more cancers' is not acceptable...

Read the whole article on

More from